Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at Sativex with temozolomide for glioblastoma brain tumour (GWCA1208)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Results

Phase:

Phase 1

Details

This trial looked at nabiximols (Sativex) with temozolomide (Temodal) for a type of brain tumour called glioblastoma. It was for people whose cancer had come back after treatment.

This trial was open for people to join between 2013 and 2015. The team published the results in 2021.

Recruitment start: 25 September 2013

Recruitment end: 14 August 2015

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Susan Short

Supported by

Experimental Cancer Medicine Centre (ECMC)

GW Pharma

Last reviewed: 17 Mar 2023

CRUK internal database number: 11645

Help and support